Champions Oncology Inc

XNAS:CSBR 3:59:50 PM EDT

6.56

-0.02 (-0.30%)

4:10:04 PM EDT: $6.50 -0.06 (-0.92%)

Market Cap (Intraday)	90.46M
Current PE	30.64
Forward PE	43.73
2yr Forward PE	43.73

See more stats

Estimates Current Quarter

Revenue	$14.04 Million
Adjusted EPS	$0.00

See more estimates

10-Day MA	$6.53
50-Day MA	$6.70
200-Day MA	$7.96

See more pivots

Champions Oncology Inc Stock, XNAS:CSBR

One University Plaza, Suite 307, Hackensack, New Jersey 07601

United States of America

Phone: +1.201.808.8400

Number of Employees: 210

http://www.championsoncology.com

Description

Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.